Arkolith/Insider Trading/HCWB/Form 4

Byam Rebecca

Chief Financial OfficerHCW Biologics Inc. (HCWB) · full profile →Form 4 · filed Jun 7, 2023
Net Buying
Open-Market Buys
$68K
Open-Market Sells
$0
Net Open-Market Flow
$68K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 6, 2023Buy(P)19K$1.82$35K499K
Jun 5, 2023Buy(P)20K$1.67$33K480K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-035121) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for HCW Biologics Inc.

Build

Ask your agent about HCWB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-23-035121"
Ask your agent
Use Arkolith to summarize insider buying and selling at HCW Biologics Inc.
over the last 90 days and cite the filings.